Replies to post #110848 on Biotech Values

[mcbio]

Re: NVS webcast/ARRY

Another upcoming webcast of interest is NVS’ annual oncology presentation tomorrow at 8am ET:

www.novartis.com/investors/presentations-events/index.shtml#2010-12-14-oncology

I'm anxious to hear to what extent NVS discusses its development plans for ARRY-162, the MEK inhibitor it licensed from ARRY.

[DewDiligence]

Slides from NVS’ oncology webcast today:

http://www.novartis.com/downloads/investors/presentations-events/broker-conferences/2010/2010-12-14-novartis-oncology.pdf